Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dishman Carbogen Amcis Limited

DCAL
Current price
212.53 INR +11.53 INR (+5.74%)
Last closed 178.89 INR
Company imdcal.com
ISIN INE385W01011
Sector Healthcare
Industry Biotechnology
Exchange National Stock Exchange of India
Capitalization 29 723 577 216 INR
Yield for 12 month +32.33 %
1Y
3Y
5Y
10Y
15Y
DCAL
21.11.2021 - 28.11.2021

Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical, healthcare, and bio-technology industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, active pharmaceutical ingredients (APIs), and general and highly potent APIs; specialty chemicals comprising intermediates, fine chemicals, phosphoranes, solid quaternary ammonium compounds, wittig reagents, and various pharmaceutical and cosmetic-related products; vitamin D products and its analogues; hand and body wash, sanitizers, and antiseptics; and phase transfer catalysts, soft gel capsules, disinfectant formulations, cholesterol, lanolin-related products, and liquid and lyophilized sterile injectables. The company was founded in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP. Address: Dishman Corporate House, Ahmedabad, India, 380058

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

13 931.49 INR

P/E ratio

Dividend Yield

Current Year

+26 169 320 000 INR

Last Year

+24 139 918 854 INR

Current Quarter

+5 240 126 820 INR

Last Quarter

+6 550 008 402 INR

Current Year

+4 905 978 429 INR

Last Year

+19 023 547 033 INR

Current Quarter

+696 309 200 INR

Last Quarter

+668 296 781 INR

Key Figures DCAL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 2 266 431 287 INR
Operating Margin TTM -7.95 %
PE Ratio
Return On Assets TTM -0.16 %
PEG Ratio
Return On Equity TTM -2.68 %
Wall Street Target Price 13 931.49 INR
Revenue TTM 24 172 433 155 INR
Book Value 359.12 INR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -27.6 %
Dividend Yield
Gross Profit TTM 17 669 345 741 INR
Earnings per share -15.83 INR
Diluted Eps TTM -15.83 INR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 315.4 %
Profit Margin -10.27 %

Dividend Analytics DCAL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

2 %

Dividend History DCAL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 12.09.2019
Forward Annual Dividend Yield
Last Split Factor 2:1
Payout Ratio
Last Split Date 02.05.2016
Dividend Date

Stock Valuation DCAL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.907
Price Sales TTM 1.2249
Enterprise Value EBITDA 16.0612
Price Book MRQ 0.528

Financials DCAL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DCAL

For 52 weeks

133.06 INR 283.13 INR
50 Day MA 188.06 INR
Shares Short Prior Month
200 Day MA 197.78 INR
Short Ratio
Shares Short
Short Percent